Evidence map›Paper›PMID 20874260›Full record

ArticleTissue engineering. Part A2011

Selective activation of sphingosine 1-phosphate receptors 1 and 3 promotes local microvascular network growth.

Lauren S Sefcik, Caren E Petrie Aronin, Anthony O Awojoodu, Soo J Shin, Feilim Mac Gabhann, Timothy L MacDonald, Brian R Wamhoff, Kevin R Lynch, Shayn M Peirce, Edward A Botchwey

Abstract read
In one paragraph

Article in Tissue engineering. Part A, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 47 citations in OpenAlex.

  1. Large differences in collateral blood vessel abundance among individuals arise from multiple genetic variants.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. An engineered macroencapsulation membrane releasing FTY720 to precondition pancreatic islet transplantation.Journal of biomedical materials research. Part B, Applied biomaterials · 2018
    Article
  8. Review
  9. Arteriogenesis in murine adipose tissue is contingent on CD68Microcirculation (New York, N.Y. : 1994) · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Lauren S SefcikDepartment of Chemical and Biomolecular Engineering, Lafayette College, Easton, Pennsylvania, USA.
Caren E Petrie Aronin
Anthony O Awojoodu
Soo J Shin
Feilim Mac Gabhann
Timothy L MacDonald
Brian R Wamhoff
Kevin R Lynch
Shayn M Peirce
Edward A Botchwey
University of Virginia · USJohns Hopkins University · USLafayette College · USNational Institute of Allergy and Infectious Diseases · US

Funding

BIOTECHNOLOGY TRAINING PROGRAMT32GM008715 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LAURIE, GORDON WILLIAM · 2000 to 2019
$6.6M
Molecular Pharmacology of Sphingosine 1-PhosphateR01GM067958 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LYNCH, KEVIN R. · 2004 to 2014
$3.7M
Arteriole/Venule Polarity in Adult MicrovasculatureR01HL082838 · NHLBI · UNIVERSITY OF VIRGINIA · PI PEIRCE-COTTLER, SHAYN · 2007 to 2011
$1.9M
Phospholipid Growth Factors for Therapeutic Arteriogenesis and Tissue EngineeringR01AR056445 · NIAMS · UNIVERSITY OF VIRGINIA · PI BOTCHWEY, EDWARD A. · 2009 to 2014
$1.8M
Therapeutic S1P Drug Targets for Cranial Bone RepairR01DE019935 · NIDCR · UNIVERSITY OF VIRGINIA · PI BOTCHWEY, EDWARD A. · 2009 to 2013
$1.8M
Vascularized Bone Grafts for Tissue EngineeringK01AR052352 · NIAMS · UNIVERSITY OF VIRGINIA · PI BOTCHWEY, EDWARD A. · 2006 to 2010
$635k
NHLBI NIH HHS R01 HL082838NIAMS NIH HHS K01 AR052352NIAMS NIH HHS K01AR052352-01A1NIAMS NIH HHS R01 AR056445NIAMS NIH HHS R01AR056445-01A2NIDCR NIH HHS R01 DE019935NIDCR NIH HHS R01DE019935-01NIGMS NIH HHS R01GM067958NIGMS NIH HHS T32GM008715
6 · The paper itself

Abstract

Proper spatial and temporal regulation of microvascular remodeling is critical to the formation of functional vascular networks, spanning the various arterial, venous, capillary, and collateral vessel systems. Recently, our group has demonstrated that sustained release of sphingosine 1-phosphate (S1P) from biodegradable polymers promotes microvascular network growth and arteriolar expansion. In this study, we employed S1P receptor-specific compounds to activate and antagonize different combinations of S1P receptors to elucidate those receptors most critical for promotion of pharmacologically induced microvascular network growth. We show that S1P(1) and S1P(3) receptors act synergistically to enhance functional network formation via increased functional length density, arteriolar diameter expansion, and increased vascular branching in the dorsal skinfold window chamber model. FTY720, a potent activator of S1P(1) and S1P(3), promoted a 107% and 153% increase in length density 3 and 7 days after implantation, respectively. It also increased arteriolar diameters by 60% and 85% 3 and 7 days after implantation. FTY720-stimulated branching in venules significantly more than unloaded poly(D, L-lactic-co-glycolic acid). When implanted on the mouse spinotrapezius muscle, FTY720 stimulated an arteriogenic response characterized by increased tortuosity and collateralization of branching microvascular networks. Our results demonstrate the effectiveness of S1P(1) and S1P(3) receptor-selective agonists (such as FTY720) in promoting microvascular growth for tissue engineering applications.

Indexed as

ActinsAnimalsDelayed-Action PreparationsFingolimod HydrochlorideMaleMiceMice, Inbred C57BLMicrovesselsModels, AnimalMusclesNeovascularization, PhysiologicPropylene GlycolsReceptors, LysosphingolipidSignal TransductionSphingosineActinsDelayed-Action PreparationsFingolimod HydrochloridePropylene GlycolsReceptors, LysosphingolipidSphingosine

Identifiers

PMID20874260
PMCPMC3043977
OpenAlexW1994507878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.